report-image

Global Biotechnology & Pharmaceutical Services Outsourcing Market Size, Industry Analysis By Segmentations, Top Key Players, Trends, Future Development & Forecast 2024-2035

  • PUBLISHED ON
  • 3/1/2023
  • NO OF PAGES
  • 260
  • CATEGORY
  • Information Technology
Biotechnology & Pharmaceutical Services Outsourcing market report presents a global overview of market shares, size, statistics, trends, demand, revenue and growth opportunities by key players, regions and countries. This report offers a complete market overview during the past, present, and the forecast period till 2032 which helps to identify future opportunities, risk factors, growing areas. Report also highlight on recent developments, technological innovations, market affecting factors, demographics analysis, demand and supply chain which gives brief strategy of market growth during the forecast period. It also gives in-depth insights on SWOT and PESTLE analysis based on industry segmentations and regional developments.

Market Overview:
The report provides a basic overview of the industry including definitions, classifications, and industry chain structure. The Biotechnology & Pharmaceutical Services Outsourcing market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as manufacturing processes and cost structures are also analyzed. This report also states import/export consumption, supply and demand, price, revenue and gross margins.

Report Scope:
The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Biotechnology & Pharmaceutical Services Outsourcing manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases. The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment by type, application and region and as a result provides a holistic view of as well as a deep insight into the Biotechnology & Pharmaceutical Services Outsourcing market covering all its essential aspects.

Global Biotechnology & Pharmaceutical Services Outsourcing Market: Segmentations


Global Biotechnology & Pharmaceutical Services Outsourcing Market: By Types
Consulting
Auditing & Assessment
Regulatory Affairs
Product Maintenance
Product Design & Development
Product Testing & Validation
Training & Education
Other

Global Biotechnology & Pharmaceutical Services Outsourcing Market: By Applications
Pharma Companies
Biotech Companies

Global Biotechnology & Pharmaceutical Services Outsourcing Market: Major Players
The Quantic Group
IQVIA
Parexel International Corporation
Lachman Consultant Services, Inc.
GMP Pharmaceuticals Pty Ltd.
Concept Heidelberg GmbH
Covance Inc.
Charles River Laboratories
PRA Health Sciences
ICON plc

Global Biotechnology & Pharmaceutical Services Outsourcing Market: By Regions
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)


Key Benefits:
• The analysis provides an overview of the factors driving and limiting the growth of the market including trends, structure and others.
• Market estimation for type and geographic segments is derived from the current market scenario and expected market trends.
• Porter’s Five Force Model and SWOT analysis are used to study the global Biotechnology & Pharmaceutical Services Outsourcing market and would help stakeholders make strategic decisions.
• The analysis assists in understanding the strategies adopted by the companies for the growth of this market.
• In-depth analysis of the types of Biotechnology & Pharmaceutical Services Outsourcing would help in identifying future applications in this market.

Reasons to Purchase this Report:
• Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors
• Provision of market value (USD Billion) data for each segment and sub-segment
• Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
• Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
• Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
• Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
• The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
• Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis
• Provides insight into the market through Value Chain
• Market dynamics scenario, along with growth opportunities of the market in the years to come
• 6-month post-sales analyst support

Objectives of the Study:
• To provide with an exhaustive analysis on the Biotechnology & Pharmaceutical Services Outsourcing Market by Product, By Application, By End User and by Region.
• To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
• To evaluate and forecast micro-markets and the overall market
• To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
• To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions
Base Year: 2023
Historic Year: 2016-2022
Forecast: 2024-2035
1 Market Overview
1.1 Product Overview and Scope of Biotechnology & Pharmaceutical Services Outsourcing
1.2 Classification of Biotechnology & Pharmaceutical Services Outsourcing by Type
1.2.1 Overview: Global Biotechnology & Pharmaceutical Services Outsourcing Market Size by Type: 2017 Versus 2022 Versus 2032
1.2.2 Global Biotechnology & Pharmaceutical Services Outsourcing Revenue Market Share by Type in 2022
1.2.3 Consulting
1.2.4 Auditing & Assessment
1.2.5 Regulatory Affairs
1.2.6 Product Maintenance
1.2.7 Product Design & Development
1.2.8 Product Testing & Validation
1.2.9 Training & Education
1.2.10 Other
1.3 Global Biotechnology & Pharmaceutical Services Outsourcing Market by Application
1.3.1 Overview: Global Biotechnology & Pharmaceutical Services Outsourcing Market Size by Application: 2017 Versus 2022 Versus 2032
1.3.2 Pharma Companies
1.3.3 Biotech Companies
1.4 Global Biotechnology & Pharmaceutical Services Outsourcing Market Size & Forecast
1.5 Global Biotechnology & Pharmaceutical Services Outsourcing Market Size and Forecast by Region
1.5.1 Global Biotechnology & Pharmaceutical Services Outsourcing Market Size by Region: 2017 VS 2022 VS 2032
1.5.2 Global Biotechnology & Pharmaceutical Services Outsourcing Market Size by Region, (2016-2021)
1.5.3 North America Biotechnology & Pharmaceutical Services Outsourcing Market Size and Prospect (2017-2032)
1.5.4 Europe Biotechnology & Pharmaceutical Services Outsourcing Market Size and Prospect (2017-2032)
1.5.5 Asia-Pacific Biotechnology & Pharmaceutical Services Outsourcing Market Size and Prospect (2017-2032)
1.5.6 South America Biotechnology & Pharmaceutical Services Outsourcing Market Size and Prospect (2017-2032)
1.5.7 Middle East and Africa Biotechnology & Pharmaceutical Services Outsourcing Market Size and Prospect (2017-2032)
1.6 Market Drivers, Restraints and Trends
1.6.1 Biotechnology & Pharmaceutical Services Outsourcing Market Drivers
1.6.2 Biotechnology & Pharmaceutical Services Outsourcing Market Restraints
1.6.3 Biotechnology & Pharmaceutical Services Outsourcing Trends Analysis
2 Company Profiles
2.1 The Quantic Group
2.1.1 The Quantic Group Details
2.1.2 The Quantic Group Major Business
2.1.3 The Quantic Group Biotechnology & Pharmaceutical Services Outsourcing Product and Solutions
2.1.4 The Quantic Group Biotechnology & Pharmaceutical Services Outsourcing Revenue, Gross Margin and Market Share (2017-2022)
2.1.5 The Quantic Group Recent Developments and Future Plans
2.2 IQVIA
2.2.1 IQVIA Details
2.2.2 IQVIA Major Business
2.2.3 IQVIA Biotechnology & Pharmaceutical Services Outsourcing Product and Solutions
2.2.4 IQVIA Biotechnology & Pharmaceutical Services Outsourcing Revenue, Gross Margin and Market Share (2017-2022)
2.2.5 IQVIA Recent Developments and Future Plans
2.3 Parexel International Corporation
2.3.1 Parexel International Corporation Details
2.3.2 Parexel International Corporation Major Business
2.3.3 Parexel International Corporation Biotechnology & Pharmaceutical Services Outsourcing Product and Solutions
2.3.4 Parexel International Corporation Biotechnology & Pharmaceutical Services Outsourcing Revenue, Gross Margin and Market Share (2017-2022)
2.3.5 Parexel International Corporation Recent Developments and Future Plans
2.4 Lachman Consultant Services, Inc.
2.4.1 Lachman Consultant Services, Inc. Details
2.4.2 Lachman Consultant Services, Inc. Major Business
2.4.3 Lachman Consultant Services, Inc. Biotechnology & Pharmaceutical Services Outsourcing Product and Solutions
2.4.4 Lachman Consultant Services, Inc. Biotechnology & Pharmaceutical Services Outsourcing Revenue, Gross Margin and Market Share (2017-2022)
2.4.5 Lachman Consultant Services, Inc. Recent Developments and Future Plans
2.5 GMP Pharmaceuticals Pty Ltd.
2.5.1 GMP Pharmaceuticals Pty Ltd. Details
2.5.2 GMP Pharmaceuticals Pty Ltd. Major Business
2.5.3 GMP Pharmaceuticals Pty Ltd. Biotechnology & Pharmaceutical Services Outsourcing Product and Solutions
2.5.4 GMP Pharmaceuticals Pty Ltd. Biotechnology & Pharmaceutical Services Outsourcing Revenue, Gross Margin and Market Share (2017-2022)
2.5.5 GMP Pharmaceuticals Pty Ltd. Recent Developments and Future Plans
2.6 Concept Heidelberg GmbH
2.6.1 Concept Heidelberg GmbH Details
2.6.2 Concept Heidelberg GmbH Major Business
2.6.3 Concept Heidelberg GmbH Biotechnology & Pharmaceutical Services Outsourcing Product and Solutions
2.6.4 Concept Heidelberg GmbH Biotechnology & Pharmaceutical Services Outsourcing Revenue, Gross Margin and Market Share (2017-2022)
2.6.5 Concept Heidelberg GmbH Recent Developments and Future Plans
2.7 Covance Inc.
2.7.1 Covance Inc. Details
2.7.2 Covance Inc. Major Business
2.7.3 Covance Inc. Biotechnology & Pharmaceutical Services Outsourcing Product and Solutions
2.7.4 Covance Inc. Biotechnology & Pharmaceutical Services Outsourcing Revenue, Gross Margin and Market Share (2017-2022)
2.7.5 Covance Inc. Recent Developments and Future Plans
2.8 Charles River Laboratories
2.8.1 Charles River Laboratories Details
2.8.2 Charles River Laboratories Major Business
2.8.3 Charles River Laboratories Biotechnology & Pharmaceutical Services Outsourcing Product and Solutions
2.8.4 Charles River Laboratories Biotechnology & Pharmaceutical Services Outsourcing Revenue, Gross Margin and Market Share (2017-2022)
2.8.5 Charles River Laboratories Recent Developments and Future Plans
2.9 PRA Health Sciences
2.9.1 PRA Health Sciences Details
2.9.2 PRA Health Sciences Major Business
2.9.3 PRA Health Sciences Biotechnology & Pharmaceutical Services Outsourcing Product and Solutions
2.9.4 PRA Health Sciences Biotechnology & Pharmaceutical Services Outsourcing Revenue, Gross Margin and Market Share (2017-2022)
2.9.5 PRA Health Sciences Recent Developments and Future Plans
2.10 ICON plc
2.10.1 ICON plc Details
2.10.2 ICON plc Major Business
2.10.3 ICON plc Biotechnology & Pharmaceutical Services Outsourcing Product and Solutions
2.10.4 ICON plc Biotechnology & Pharmaceutical Services Outsourcing Revenue, Gross Margin and Market Share (2017-2022)
2.10.5 ICON plc Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Biotechnology & Pharmaceutical Services Outsourcing Revenue and Share by Players (2017-2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Biotechnology & Pharmaceutical Services Outsourcing Players Market Share
3.2.2 Top 10 Biotechnology & Pharmaceutical Services Outsourcing Players Market Share
3.2.3 Market Competition Trend
3.3 Biotechnology & Pharmaceutical Services Outsourcing Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Biotechnology & Pharmaceutical Services Outsourcing Revenue and Market Share by Type (2016-2021)
4.2 Global Biotechnology & Pharmaceutical Services Outsourcing Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Biotechnology & Pharmaceutical Services Outsourcing Revenue Market Share by Application (2016-2021)
5.2 Biotechnology & Pharmaceutical Services Outsourcing Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Biotechnology & Pharmaceutical Services Outsourcing Revenue by Type (2017-2032)
6.2 North America Biotechnology & Pharmaceutical Services Outsourcing Revenue by Application (2017-2032)
6.3 North America Biotechnology & Pharmaceutical Services Outsourcing Market Size by Country
6.3.1 North America Biotechnology & Pharmaceutical Services Outsourcing Revenue by Country (2017-2032)
6.3.2 United States Biotechnology & Pharmaceutical Services Outsourcing Market Size and Forecast (2017-2032)
6.3.3 Canada Biotechnology & Pharmaceutical Services Outsourcing Market Size and Forecast (2017-2032)
6.3.4 Mexico Biotechnology & Pharmaceutical Services Outsourcing Market Size and Forecast (2017-2032)
7 Europe by Country, by Type, and by Application
7.1 Europe Biotechnology & Pharmaceutical Services Outsourcing Revenue by Type (2017-2032)
7.2 Europe Biotechnology & Pharmaceutical Services Outsourcing Revenue by Application (2017-2032)
7.3 Europe Biotechnology & Pharmaceutical Services Outsourcing Market Size by Country
7.3.1 Europe Biotechnology & Pharmaceutical Services Outsourcing Revenue by Country (2017-2032)
7.3.2 Germany Biotechnology & Pharmaceutical Services Outsourcing Market Size and Forecast (2017-2032)
7.3.3 France Biotechnology & Pharmaceutical Services Outsourcing Market Size and Forecast (2017-2032)
7.3.4 United Kingdom Biotechnology & Pharmaceutical Services Outsourcing Market Size and Forecast (2017-2032)
7.3.5 Russia Biotechnology & Pharmaceutical Services Outsourcing Market Size and Forecast (2017-2032)
7.3.6 Italy Biotechnology & Pharmaceutical Services Outsourcing Market Size and Forecast (2017-2032)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Biotechnology & Pharmaceutical Services Outsourcing Revenue by Type (2017-2032)
8.2 Asia-Pacific Biotechnology & Pharmaceutical Services Outsourcing Revenue by Application (2017-2032)
8.3 Asia-Pacific Biotechnology & Pharmaceutical Services Outsourcing Market Size by Region
8.3.1 Asia-Pacific Biotechnology & Pharmaceutical Services Outsourcing Revenue by Region (2017-2032)
8.3.2 China Biotechnology & Pharmaceutical Services Outsourcing Market Size and Forecast (2017-2032)
8.3.3 Japan Biotechnology & Pharmaceutical Services Outsourcing Market Size and Forecast (2017-2032)
8.3.4 South Korea Biotechnology & Pharmaceutical Services Outsourcing Market Size and Forecast (2017-2032)
8.3.5 India Biotechnology & Pharmaceutical Services Outsourcing Market Size and Forecast (2017-2032)
8.3.6 Southeast Asia Biotechnology & Pharmaceutical Services Outsourcing Market Size and Forecast (2017-2032)
8.3.7 Australia Biotechnology & Pharmaceutical Services Outsourcing Market Size and Forecast (2017-2032)
9 South America by Country, by Type, and by Application
9.1 South America Biotechnology & Pharmaceutical Services Outsourcing Revenue by Type (2017-2032)
9.2 South America Biotechnology & Pharmaceutical Services Outsourcing Revenue by Application (2017-2032)
9.3 South America Biotechnology & Pharmaceutical Services Outsourcing Market Size by Country
9.3.1 South America Biotechnology & Pharmaceutical Services Outsourcing Revenue by Country (2017-2032)
9.3.2 Brazil Biotechnology & Pharmaceutical Services Outsourcing Market Size and Forecast (2017-2032)
9.3.3 Argentina Biotechnology & Pharmaceutical Services Outsourcing Market Size and Forecast (2017-2032)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Biotechnology & Pharmaceutical Services Outsourcing Revenue by Type (2017-2032)
10.2 Middle East & Africa Biotechnology & Pharmaceutical Services Outsourcing Revenue by Application (2017-2032)
10.3 Middle East & Africa Biotechnology & Pharmaceutical Services Outsourcing Market Size by Country
10.3.1 Middle East & Africa Biotechnology & Pharmaceutical Services Outsourcing Revenue by Country (2017-2032)
10.3.2 Turkey Biotechnology & Pharmaceutical Services Outsourcing Market Size and Forecast (2017-2032)
10.3.3 Saudi Arabia Biotechnology & Pharmaceutical Services Outsourcing Market Size and Forecast (2017-2032)
10.3.4 UAE Biotechnology & Pharmaceutical Services Outsourcing Market Size and Forecast (2017-2032)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

Quality Assurance Process

  1. We Market Research’s Quality Assurance program strives to deliver superior value to our clients.

We Market Research senior executive is assigned to each consulting engagement and works closely with the project team to deliver as per the clients expectations.

Market Research Process




We Market Research monitors 3 important attributes during the QA process- Cost, Schedule & Quality. We believe them as a critical benchmark in achieving a project’s success.

To mitigate risks that can impact project success, we deploy the follow project delivery best practices:
  • Project kickoff meeting with client
  • Conduct frequent client communications
  • Form project steering committee
  • Assign a senior SR executive as QA Executive
  • Conduct internal editorial & quality reviews of project deliverables
  • Certify project staff in SR methodologies & standards
  • Monitor client satisfaction
  • Monitor realized value post-project

Case Study- Automotive Sector

One of the key manufacturers of automotive had plans to invest in electric utility vehicles. The electric cars and associated markets being a of evolving nature, the automotive client approached Straits Research for a detailed insight on the market forecasts. The client specifically asked for competitive analysis, regulatory framework, regional prospects studied under the influence of drivers, challenges, opportunities, and pricing in terms of revenue and sales (million units).

Solution

The overall study was executed in three stages, intending to help the client meet its objective of precisely understanding the entire market before deciding on an investment. At first, secondary research was conducted considering political, economic, social, and technological parameters to get a gist of the various aspects of the market. This stage of the study concluded with the derivation of drivers, opportunities, and challenges. It also laid substantial emphasis on understanding and collecting data not only on a global scale but also on the regional and country levels. Data Extraction through Primary Research

The second stage involved primary research in which several market players and automotive parts suppliers were contacted to study their viewpoint concerning the development of their market and production capacity, clientele, and product line. This stage concluded in a brief understanding of the competitive ecosystem and also glanced through the strategies and pricing of the companies profiled.

Market Estimates and Forecast

In the final stage of the study, market forecasts for the electric utility were derived using multiple market engineering approaches. This data helped the client to get an overview of the market and accelerate the process of investment.

Case Study- ICT Sector

Business process outsourcing, being one of the lucrative markets from both supply- and demand- side, has appealed to various companies. One of the prominent corporations based out of Japan approached us with their requirements regarding the scope of the procurement outsourcing market for around 50 countries. Additionally, the client also sought key players operating in the market and their revenue breakdown in terms of region and application.


Business Solution

An exhaustive market study was conducted based on primary and secondary research that involved factors such as labor costs in various countries, skilled and technical labors, manufacturing scenario, and their respective contributions in the global GDP. A comparative study of the market was conducted from both supply- and demand side, with the supply-side comprising of notable companies, such as GEP, Accenture, and others, that provide these services. On the other hand, large manufacturing companies from them demand-side were considered that opt for these services.


Conclusion

The report aided the client in understanding the market trends, including country-level business scenarios, consumer behavior, and trends in 50 countries. The report also provided financial insights of crucial players and detailed market estimations and forecasts till 2028.

CHOOSE LICENSE TYPE
QLOUD
Pricing

Select a license type that suits your business needs

Single User Access

US $3950

Only Three Thousand Nine Hundred Fifty US dollar

  • 1 User access
  • 15% Additional Free Customization
  • Free Unlimited post-sale support
  • 100% Service Guarantee until achievement of ROI
Multi User Cost

US $4950

Only Four Thousand Nine Hundred Fifty US dollar

  • 5 Users access
  • 25% Additional Free Customization
  • Access Report summaries for Free
  • Guaranteed service
  • Dedicated Account Manager
  • Discount of 20% on next purchase
  • Get personalized market brief from Lead Author
  • Printing of Report permitted
  • Discount of 20% on next purchase
  • 100% Service Guarantee until achievement of ROI
Enterprise User Cost

US $5950

Only Five Thousand Nine Hundred Fifty US dollar

  • Unlimited User Access
  • 30% Additional Free Customization
  • Exclusive Previews to latest or upcoming reports
  • Discount of 30% on next purchase
  • 100% Service Guarantee until achievement of ROI